Steven M Corsello

Title: Steven M Corsello: Innovator in Cancer Treatment

Introduction

Steven M Corsello is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of 2 patents, Corsello's work is focused on innovative solutions for proliferative disorders.

Latest Patents

Corsello's latest patents include a compound known as 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one, which serves as a CSNK1 inhibitor. This invention relates to compounds that inhibit Casein kinase 1 alpha and/or delta (CSNK1α and/or β), which are useful for treating proliferative disorders. Additionally, he has developed compounds and methods that are beneficial for treating or preventing various cancers, including hematological cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), as well as colon cancer.

Career Highlights

Corsello has worked with esteemed organizations such as Dana-Farber Cancer Institute Inc. and The Broad Institute, Inc. His experience in these institutions has allowed him to contribute to groundbreaking research and development in cancer therapies.

Collaborations

Some of his notable coworkers include Volker Schulze and Anne Mengel. Their collaborative efforts have further advanced the research in the field of cancer treatment.

Conclusion

Steven M Corsello is a dedicated inventor whose work in developing innovative cancer treatments has the potential to make a significant impact in the medical field. His contributions through patents and collaborations highlight his commitment to advancing healthcare solutions.